The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.
Millions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $35 ...
The Biden administration is proposing a major expansion of how Medicare and Medicaid cover the weight-loss drugs Wegovy and ...
About 42% of U.S. adults are obese, the CDC says. GLP-1 medications have changed the picture for people hoping to reduce ...
Millions of obese Americans would be eligible to have popular weight-loss drugs like Wegovy or Zepbound covered by Medicare ...
Share on Facebook Share on Twitter Under a new rule the Biden administration proposed on Tuesday, millions of Americans with ...
There is some debate as to whether GLP-1 agonist drugs like Wegovy can lead to unhealthy muscle mass loss in addition to ...
Zepbound, a drug used to help patients lose weight and manage diabetes, may also help those with heart failure, a new trial ...
The Biden administration is looking to extend Medicare and Medicaid coverage to include obesity drugs like Wegovy and Zepbound. Weight loss drugs are now excluded from mandatory coverage.
The cutting-edge weight-loss drug Zepbound can protect obese people from developing type 2 diabetes, a new clinical ...
America's kitchen trash bins are receiving more unwanted food as appetites falter among people taking GLP-1 weight-loss meds, ...